The AITC program at a glance.
Fueling breakthrough ideas for healthier tomorrows.
Phase I
Formerly the a2 Collective, the AITC program has funded 166 AI-driven AgeTech projects with more than $40M (opens in a new tab) to improve care and health outcomes for older adults, including persons with Alzheimer’s disease and related dementias (AD/ADRD).
Pilot awardees may receive access to study sites, datasets, and resources at each AITC, as well as mentorship from industry and university experts, major health systems, and venture capitalists. Pilot awardees may also become more competitive for SBIR/STTR grant funding.
- P30 sites
- 3
- AI-driven AgeTech projects
- 166
- In program funding to date
- $40M+
Phase II (current phase)
Projected targets for the current phase of the AITC program.
- Projects~1.8× Phase I
- Program funding~2.5× Phase I
- P30 sites
- 5
- Estimated projects
- 300
- In program funding
- $100M





